Poly(lactic acid) (PLA) and poly(ethylene glycol) (PEG) were melt-blended and extruded into films in the PLA/PEG ratios of 100/0, 90/10, 70/30, 50/50, and 30/ 70. It was concluded from the differential scanning calorimetry and dynamic mechanical analysis results that PLA/PEG blends range from miscible to partially miscible, depending on the concentration. Below 50% PEG content the PEG plasticized the PLA, yielding higher elongations and lower modulus values. Above 50% PEG content the blend morphology was driven by the increasing crystallinity of PEG, resulting in an increase in modulus and a corresponding decrease in elongation at break. The tensile strength was found to decrease in a linear fashion with increasing PEG content. Results obtained from enzymatic degradation show that the weight loss for all of the blends was significantly greater than that for the pure PLA. When the PEG content was 30% or lower, weight loss was found to be primarily due to enzymatic degradation of the PLA. Above 30% PEG content, the weight loss was found to be mainly due to the dissolution of PEG. During hydrolytic degradation, for PLA/PEG blends up to 30% PEG, weight loss occurs as a combination of degradation of PLA and dissolution of PEG.

Citrate esters were used as plasticizers with poly(lactic acid) (PLA). Films were extruded using a single-screw extruder with plasticizer contents of 10, 20, and 30% by weight. All of the citrate esters investigated were found to be effective in reducing the glass transition temperature and improving the elongation at break. It was observed that the plasticizing efficiency was higher for the intermediate-molecularweight plasticizers. Hydrolytic and enzymatic degradation tests were conducted on these films. It was found that the lower-molecular-weight citrates increased the enzymatic degradation rate of PLA and the higher-molecular-weight citrates decreased the degradation rate as compared with that of unplasticized PLA.

We report the ring-opening polymerization reaction of ε-caprolactone in supercritical carbon dioxide (scCO2) using an enzyme catalyst, Lipase B from Candida antarctica supported on macroporous beads (Novozym-435). Ring-opening polymerization of lactones is more commonly performed in organic solvents or in bulk using a Lewis acid catalyst. Recently there has been much interest in the replacement of such catalysts by enzymes. We demonstrate that the enzymatic route is viable in scCO2, yielding poly(ε-caprolactone) (M n = 12 000−37 000 g mol-1) with molecular weights very similar to those obtained from the same enzyme catalysts in organic solvents, but with lower polydispersities (typical PDI = 1.4−1.6) and higher yields of polymer product (typically 95−98%). In the same process the unique “gaslike” mass transfer properties of scCO2 can also be exploited to remove quantitatively any unconverted monomer and low molecular weight oligomers by scCO2 extraction. It is also shown that the enzyme catalyst can be cleaned and recycled using scCO2, while still producing high molecular weight polymer (M n = 35 000−37 000 g mol-1). Thus, a combination of enzyme catalyst and scCO2 can be used repeatedly to prepare biodegradable poly(ε-caprolactone) (PCL) in the complete absence of potentially toxic organic solvents or metal catalysts.

No abstract

A chemoenzymatic approach has been developed to synthesize poly(ethylene glycol)-based amphiphilic copolymers under mild reaction conditions that self-assemble in aqueous media to form polymeric nanomicelles in the range of 20-50 nm. The supramolecular organization of polymeric nanomicelles was studied by 1H NMR longitudinal relaxation time (T1) and light scattering techniques (static and dynamic). Interestingly, the enzyme novozyme-435 plays an important role in controlling the polymerization and distribution of polymer chains, which is critical for the formation of nanomicelles with unimodal distributions. The methodology developed is highly flexible as it allows the introduction of various functionalities in the polymeric nanomicelles. These self-organized nanomicelles are highly efficient drug delivery vehicles for hydrophobic and partially hydrophilic drugs, both transdermally and orally, as they have the ability to encapsulate guest molecules during self-organization. In vivo studies by encapsulating anti-inflammatory agents (aspirin and naproxen) in these polymeric nanomicelles and by applying topically resulted in significant reduction in inflammation. The % reduction in inflammation using polymeric nanomicelles containing aspirin and naproxen was 62 and 64%, respectively.